journal article·2026-01Open access

HUWE1 in Skeletal Muscle Prevents Muscle Fatigue via Maintaining Iron and Calcium Homeostasis

Huike Jiao, Yuting Du, Danxia Zhou, Meng Bai, Xu Gao, Zhenyue Hao, Nan‐Jie Xu, Jiaqiang Liu, Ying Huang, Zhenji Gan, Jing Zhang

Advanced Science· Volume 13· Issue 4

Abstract

Abstract Iron is critical to optimal athletic performance because of its role in energy metabolism, oxygen transport, and acid‐base balance. However, the precise mechanism how skeletal muscle maintains iron homeostasis during exercise remains enigmatic. Here, it is demonstrated that the HECT‐domain containing ubiquitin ligase E3 Huwe1 (also known as MULE or ARF‐BP1) in skeletal muscle is suppressed upon exhausted exercise. Loss of Huwe1 in skeletal muscle restrains the exercise performance of Huwe1 conditional knockout (cKO) mice, accompanied with pronounced oxidative stress. Mechanistically, Huwe1 depletion stabilizes c‐Myc protein, leading to upregulated sarcolipin (Sln) expression with inhibited SarcoEndoplasmic Reticulum Calcium ATPase (SERCA) activity, and downregulated ferroportin (Fpn, also known as Slc40a1) expression with iron overload. Silencing of c‐Myc restores SERCA activity and iron export. Consistently, SERCA activator CDN1163, Sln silencing, or dietary iron restriction ameliorates the exercise performance of Huwe1 cKO mice. Of note, improved exercise performance is accompanied with diminished oxidative stress in Huwe1 cKO mice upon iron restriction. Taken together, the results unveil a key function for HUWE1 in skeletal muscle as a fundamental coordinator of iron and calcium homeostasis by regulating SERCA activity and iron metabolism. These findings reveal a regulatory pathway on controlling iron/calcium homeostasis and exercise capacity.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Cancer, Hypoxia, and Metabolism · Ferroptosis and cancer prognosis · Iron Metabolism and Disorders

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Institute for Translational Medicine on Cell Fate and Disease Shanghai Ninth People's Hospital Key Laboratory of Cell Differentiation and Apoptosis of National Ministry of Education Department of Pathophysiology Shanghai Jiao Tong University School of Medicine Shanghai 200025 China

Key Laboratory of Cell Differentiation and Apoptosis of National Ministry of Education Department of Pathophysiology Shanghai Jiao Tong University School of Medicine Shanghai 200025 China

The State Key Laboratory of Pharmaceutical Biotechnology and MOE Key Laboratory of Model Animal for Disease Study Model Animal Research Center Nanjing University Medical School Nanjing University Nanjing 210000 China

Princess Margaret Cancer Centre University Health Network Toronto ON M5G 2C1 Canada

Songjiang Hospital and Songjiang Research Institute Shanghai Key Laboratory of Emotions and Affective Disorders Shanghai Jiao Tong University School of Medicine Shanghai 201600 China

Department of Oral and Cranio‐maxillofacial Surgery Shanghai Ninth People's Hospital Shanghai Jiao Tong University School of Medicine Shanghai 200011 China

Funding

Key Technologies Research and Development Program · National Natural Science Foundation of China

References (50)

Show source-provided references
1. 10.1152/japplphysiol.00073.200210.1152/japplphysiol.00073.2002 ↗
2. 10.1113/JP27064610.1113/JP270646 ↗
3. 10.1152/physrev.00031.200710.1152/physrev.00031.2007 ↗
4. 10.1002/j.2040-4603.2011.tb00348.x10.1002/j.2040-4603.2011.tb00348.x ↗
5. 10.1074/jbc.M00071320010.1074/jbc.M000713200 ↗
6. 10.1038/3500159610.1038/35001596 ↗
7. 10.1016/S1097-2765(00)80425-610.1016/S1097-2765(00)80425-6 ↗
8. 10.1016/j.cmet.2005.01.00310.1016/j.cmet.2005.01.003 ↗
9. 10.1016/j.bcmd.2010.07.00210.1016/j.bcmd.2010.07.002 ↗
10. 10.1113/expphysiol.2008.04604510.1113/expphysiol.2008.046045 ↗
11. 10.1159/00035676010.1159/000356760 ↗
12. 10.1093/gerona/61.10.99510.1093/gerona/61.10.995 ↗
13. 10.1073/pnas.033096210010.1073/pnas.0330962100 ↗
14. 10.1186/s13395-021-00280-710.1186/s13395-021-00280-7 ↗
15. 10.1016/j.redox.2018.09.01810.1016/j.redox.2018.09.018 ↗
16. 10.1136/bmjopen-2015-00953710.1136/bmjopen-2015-009537 ↗
17. 10.1016/j.cell.2005.08.01610.1016/j.cell.2005.08.016 ↗
18. 10.1016/j.cell.2005.03.03710.1016/j.cell.2005.03.037 ↗
19. 10.1016/j.cell.2005.06.00910.1016/j.cell.2005.06.009 ↗
20. 10.1101/gad.170605.11110.1101/gad.170605.111 ↗
21. 10.1186/s12929-018-0470-010.1186/s12929-018-0470-0 ↗
22. 10.1038/s41418-022-00957-610.1038/s41418-022-00957-6 ↗
23. 10.3390/ijms2203120810.3390/ijms22031208 ↗
24. 10.1016/j.bbrc.2015.05.01210.1016/j.bbrc.2015.05.012 ↗
25. 10.1016/j.cardiores.2004.08.01210.1016/j.cardiores.2004.08.012 ↗
26. 10.1152/ajpcell.00291.201610.1152/ajpcell.00291.2016 ↗
27. Fajardo V. A. · Hum. Mol. Genet. · 2018 · 27 · 4094
28. 10.1016/j.cmet.2005.01.00310.1016/j.cmet.2005.01.003 ↗
29. 10.3389/fnut.2018.0010310.3389/fnut.2018.00103 ↗
30. 10.1038/nature1347310.1038/nature13473 ↗
31. 10.1155/2021/384612210.1155/2021/3846122 ↗
32. 10.3390/antiox704005010.3390/antiox7040050 ↗
33. 10.1038/s41580-020-0230-310.1038/s41580-020-0230-3 ↗
34. 10.1016/j.cell.2007.11.02810.1016/j.cell.2007.11.028 ↗
35. 10.1172/JCI14916010.1172/JCI149160 ↗
36. 10.1177/108705711245687810.1177/1087057112456878 ↗
37. 10.1016/j.bmc.2016.10.00810.1016/j.bmc.2016.10.008 ↗
38. 10.1016/j.cell.2014.10.02910.1016/j.cell.2014.10.029 ↗
39. 10.1016/j.celrep.2022.11105810.1016/j.celrep.2022.111058 ↗
40. 10.1016/j.cell.2020.04.04310.1016/j.cell.2020.04.043 ↗
41. 10.1038/srep4149010.1038/srep41490 ↗
42. 10.14814/phy2.1528510.14814/phy2.15285 ↗
43. 10.1681/ASN.200607080210.1681/ASN.2006070802 ↗
44. 10.1016/j.cmet.2013.02.00410.1016/j.cmet.2013.02.004 ↗
45. 10.15252/embr.20215374610.15252/embr.202153746 ↗
46. 10.1002/jcsm.1268510.1002/jcsm.12685 ↗
47. 10.1084/jem.2011136310.1084/jem.20111363 ↗
48. 10.1126/sciadv.abo034010.1126/sciadv.abo0340 ↗
49. Kim H. · J Vis Exp. · 2020 · 23 · 10
50. 10.1186/s13395-020-00250-510.1186/s13395-020-00250-5 ↗